KRAS and non-small cell lung carcinoma: Thus, the combination of Gem+Carbo effectively enhances the sensitivity of KRAS-G12C-mutated NSCLC cell lines to KRASi, with both sequential and concurrent treatment strategies, achieving significant reductions in cell viability.